Vimarsana
Biggest News Aggregation in the World

Page 3 - Neha Mathurjun News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neha Mathurjun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neha Mathurjun Today - Breaking & Trending Today

Scientists explore brainstem circuits to find nausea intervention strategies - Vimarsana News

Scientists explore brainstem circuits to find nausea intervention strategies

In a new study, researchers uncovered the organization of nausea-associated brainstem circuits to show that selectively blocking the excitatory neurons responsive to nausea-promoting growth/differentiation factor 15 suppresses nausea-related behaviors.

Implications of impaired type I interferon immunity and increasing COVID-19 severity - Vimarsana News

Implications of impaired type I interferon immunity and increasing COVID-19 severity

Researchers demonstrated that impaired type I interferon immunity is associated with increasing coronavirus disease 2019 severity.

GPR183 gene a novel drug target for severe COVID-19 - Vimarsana News

GPR183 gene a novel drug target for severe COVID-19

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known as Epstein-Barr virus-induced gene 2 (EBI2), in reducing coronavirus disease 2019 (COVID-19) severity.

Even mild respiratory COVID can affect the brain - Vimarsana News

Even mild respiratory COVID can affect the brain

In a recent study published in the journal Cell, researchers explored neurological symptoms and subsequent cognitive impairment experienced by survivors of mild respiratory coronavirus disease 2019 (COVID-19).

Even mild espiratory COVID can affect the brain - Vimarsana News

Even mild espiratory COVID can affect the brain

In a recent study published in the journal Cell, researchers explored neurological symptoms and subsequent cognitive impairment experienced by survivors of mild respiratory coronavirus disease 2019 (COVID-19).